ANTIFON-CLIC®, a new clinical decision support system for the treatment of invasive aspergillosis: is it clinically relevant?

Ann Pharm Fr. 2024 May;82(3):514-521. doi: 10.1016/j.pharma.2023.11.002. Epub 2023 Nov 22.

Abstract

Background: Invasive aspergillosis (IA) is increasing especially in new groups of patients. Despite advances in management, morbidity and mortality related to IA remain high. Thus, Clinical Decision Support System (CDSS) dedicated to IA are needed to promote the optimal antifungal for each group of patients.

Patients and methods: This was a retrospective multicenter cohort study involving intensive care units and medical units. Adult patients who received caspofungin, isavuconazole, itraconazole, liposomal amphotericin B, posaconazole, or voriconazole, for the treatment of IA were eligible for enrollment. The primary objective was the concordance between the clinician's prescription and the prescription recommended by the CDSS. The secondary objective was the concordance according to different hospitals, departments, and indications.

Results: Eighty-eight patients (n=88) from three medical hospitals were included. The overall concordance was 97% (85/88) including 100% (41/41) for center A, 92% (23/25) for center B, and 95% (21/22) for center C. There was no significant difference in concordance among the hospitals (P=0.973), the departments (P=1.000), and the indications (P=0.799). The concordance was 70% (7/10) for isavuconazole due to its use as an empirical treatment and 100% (78/78) for the other antifungals.

Discussion: The concordance rate was high whatever the hospital, the department, and the indication. The only discrepancy was attributed to the use of isavuconazole as an empirical treatment which is a therapeutic option not included in the CDSS.

Conclusions: This new CDSS dedicated to IA is meeting the clinical practice. Its implementation in routine will help to support antifungal stewardship.

Keywords: Aspergillose invasive; Clinical Decision Support System; Clinical evaluation; Clinical practice; Invasive aspergillosis; Multicentric study; Outil d’aide à la décision; Pratique clinique; Étude multicentrique; Évaluation clinique.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Antifungal Agents / therapeutic use
  • Aspergillosis* / drug therapy
  • Cohort Studies
  • Decision Support Systems, Clinical*
  • Humans
  • Nitriles*
  • Pyridines*
  • Triazoles*

Substances

  • Antifungal Agents
  • isavuconazole
  • Nitriles
  • Pyridines
  • Triazoles